Literature DB >> 8547657

High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia.

D Douer1, S Preston-Martin, E Chang, P W Nichols, K J Watkins, A M Levine.   

Abstract

A high frequency (24%) of acute promyelocytic leukemia (APL) was noted among acute myelocytic leukemia (AML) cases at the Los Angeles County-University of Southern California (LAC-USC) Medical Center, in comparison with the expected frequency of 5% to 15%. Because of the high proportion of Latinos in this center, we questioned if APL is more common in this ethnic group. The proportion of APL among the 80 AML patients of Latino origin was significantly higher (30; 37.5%) when compared with the 62 non-Latinos (4; 6.5%) (P = .00001). In an attempt to verify this finding on a larger group of patients, we analyzed 276 pathologically verified cases of AML in patients aged 30 to 69 years from the entire County of Los Angeles, registered on an ongoing population-based epidemiologic study of AML. APL was more frequent among the 47 Latinos (24.3%) than in the 229 non-Latinos (8.3%) (P = .0075). APL is seen in younger patients with AML, but Latino AML patients also had a higher frequency of APL after accounting for their younger age (age-adjusted odds ratio for APL among Latinos in LAC-USC Medical Center, 9.4 [95% confidence interval (CI) 2.9, 30] P = .0002; among Latinos in the population-based study, 3.0 [95% CI 1.3 to 6.9] P = .01). The different ethnic distribution of AML was found to be due to a higher proportion of APL cases per se, and not to a lower proportion of any other French-American-British subtype (P = .0004). These results, from two different populations of AML patients, indicate that Latinos with AML have a higher likelihood of the APL subtype of disease, which may suggest a genetic predisposition to APL and/or exposure to distinct environmental factor(s).

Entities:  

Mesh:

Year:  1996        PMID: 8547657

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.

Authors:  A G Dinmohamed; O Visser; Y van Norden; N M A Blijlevens; J J Cornelissen; G A Huls; P C Huijgens; P Sonneveld; A A van de Loosdrecht; G J Ossenkoppele; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-17       Impact factor: 11.528

2.  Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.

Authors:  Geetanjali R Kamath; Douglas Tremblay; Alexander Coltoff; Jessica Caro; Guido Lancman; Sheena Bhalla; Vesna Najfeld; John Mascarenhas; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2019-07-04       Impact factor: 4.944

3.  Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet-a population-based study.

Authors:  Avinash G Dinmohamed; Otto Visser
Journal:  Stem Cell Investig       Date:  2019-11-26

4.  Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review.

Authors:  K Kuriyama; M Tomonaga; T Kobayashi; J Takeuchi; T Ohshima; S Furusawa; K Saitoh; R Ohno
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 5.  New advances in the treatment of acute promyelocytic leukemia.

Authors:  Dan Douer
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 6.  Acute myelogenous leukemia in adolescents and young adults.

Authors:  Ursula Creutzig; Matthew A Kutny; Ronald Barr; Richard F Schlenk; Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2018-04-18       Impact factor: 3.167

7.  Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model.

Authors:  Pier Paolo Scaglioni; Lu Fan Cai; Samia M Majid; Thomas M Yung; Nicholas D Socci; Scott C Kogan; Levy Kopelovich; Pier Paolo Pandolfi
Journal:  Genes Cancer       Date:  2011-02

Review 8.  Management of acute promyelocytic leukemia.

Authors:  Martin S Tallman; Chadi Nabhan
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

9.  Role of arsenic trioxide in acute promyelocytic leukemia.

Authors:  Harry J Iland; John F Seymour
Journal:  Curr Treat Options Oncol       Date:  2013-06

10.  Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective study.

Authors:  Justin P Lee; Elliott Birnstein; David Masiello; Dongyun Yang; Allen S Yang
Journal:  J Hematol Oncol       Date:  2009-07-24       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.